1.Changes of apoptosis and caspase-3 activity and the effects of Ac-DEVD-CHO in cardiomyocytes of rats with myocardial reperfusion injury
Qiang XU ; Liangyi SI ; Xiaolan ZHAO ; Zhang WANG ;
Journal of Third Military Medical University 2003;0(15):-
Objective To observe the changes of apoptosis and caspase 3 activity in cardiomyocytes of rats at different time points after transient ischemia and the effects of caspase 3 inhibitor Ac DEVD CHO on reperfusion injury Methods A total of 122 rats were divided randomly into 3 groups: IR group, IR+Ac DEVD CHO group and sham group The ischemic samples were observed at 30 min after ischemia followed by reperfusion at 1, 3, 6, 12 and 24 h The apoptotic cardiomyocytes, the activity of caspase 3 and the myocardial infarction area were determined by TUNEL method, fluorescent assay and TTC dyeing method, respectively Results Apoptosis index(AI) of cardiomyocyte and caspase 3 activity changed in a time dependent manner Highest AI and caspase 3 were found after reperfusion at 12 h The myocardial infarction area in group IR kept increasing during the period of reperfusion AI and caspase 3 activity were positively correlated with the myocardial infarction area( P
3.Research Analysis on Medication Compliances of Tuberculosis Patients
Liangyi ZHAO ; Xiaoyan XIE ; Yanhong SHEN ; Yanxin SHAO ; Yan GUO
China Pharmacy 2005;0(17):-
OBJECTIVE:To probe into the status quo of medication compliances and problems in the medication of patients with tuberculosis so as to direct their use of drugs.METHODS:Information on medication compliances of tuberculosis patients who experienced regular physical examinations was investigated by interview and questionnaires,and which were analyzed statistically.RESULTS:Of the562cases investigated,54%followed or almost followed medication directions;46%failed to follow normal drug therapy for different reasons.CONCLUSION:The pharmacists should do their utmost to expand the range of pharmaceutical care so as to improve patients'medication compliances.
4.Intra-articular injection of etanercept into the sacroiliac joint of ankylosing spondylitis
Yang CUI ; Xiao ZHANG ; Shuxia WANG ; Zhenjun ZHAO ; Hengguo ZHUANG ; Liangyi FANG ; Weicheng GAO ; Li LIN ; Guangfeng ZHANG ; Yunzhen SHI ; Guangfu DONG
Chinese Journal of Rheumatology 2010;14(6):381-387
Objective To evaluated intra-articular injection of TNF-α inhibitors into the sacroiliac joint as an effective and viable alternative. Methods Sixteen patients with documented ankylosing spondylitis (AS), without steroids or disease modifying anti-rheumatic drugs (DMARDs) were performed CT-guided intra-articular injections of etanercept (TNF-α antagonist) at week 0, 4 and 8 (25 mg per dose). Similarly, 20 patients with AS in the control group received systemic etanercept therapy at a dose of 50 mg per week for 8 weeks. All patients were followed up clinically and evaluated periodically. Pathological features of sacroiliitis were observed with light microscopy and immunohistochemistry. Expression of cytokines in joint biopsy samples was estimated by RT-PCR. Image changes of sacroiliitis were observed by SPECT/CT and MRI. Ttest, t'tesr and χ2 Fisher's test were selected. Results All the 16 patients who received intra-articular etanercept, the mean value of radiological nuclide decrease of the SIJ ROI (region of interest) in the SPECT improved significantly after 8 weeks treatment [(1.38±0.16 vs 1.45±0.14) P<0.05] . Bone marrow edema and fat deposition in MRI were relieved significantly after 8 weeks (P<0.05). In 8 patients the expression of TNF-α and TGF-β mRNA in joint tissue decreased significantly after 8 weeks [(0.89±0.06, 0.84±0.05) vs (l.08± 0.19, 1.13±0.33) (P<0.05)]. The occurrence of gynonitis, enthesitis, chondritis, subehondral bony plate destruction, bone marrow inflammation and inflammatory cell index also decreased significantly (P<0.05). Participants given intra-articular injection showed significant clinical improvement after 8 weeks and 12 weeks treatment(P<0.01 ) in BASDAI score [(32±13) mm]. Conclusion This study has shown that intra-articular injection of etanercept in SIJ can improve joint function and quality of life. It has a satisfactory safety profile and is cost effective. This mode of treatment is most beneficial in local arthropathy of recent onset and in those patients who do not tolerate systemic etanercept therapy.
5.Bulk-like endocytosis plays an important role in the recycling of insulin granules in pancreatic beta cells.
Du WEN ; Yanhong XUE ; Kuo LIANG ; Tianyi YUAN ; Jingze LU ; Wei ZHAO ; Tao XU ; Liangyi CHEN
Protein & Cell 2012;3(8):618-626
Although bulk endocytosis has been found in a number of neuronal and endocrine cells, the molecular mechanism and physiological function of bulk endocytosis remain elusive. In pancreatic beta cells, we have observed bulk-like endocytosis evoked both by flash photolysis and trains of depolarization. Bulk-like endocytosis is a clathrin-independent process that is facilitated by enhanced extracellular Ca(2+) entry and suppressed by the inhibition of dynamin function. Moreover, defects in bulk-like endocytosis are accompanied by hyperinsulinemia in primary beta cells dissociated from diabetic KKAy mice, which suggests that bulk-like endocytosis plays an important role in maintaining the exo-endocytosis balance and beta cell secretory capability.
Animals
;
Calcium
;
metabolism
;
Cytoplasmic Granules
;
metabolism
;
Diabetes Mellitus
;
metabolism
;
pathology
;
Disease Models, Animal
;
Dynamins
;
metabolism
;
Electric Capacitance
;
Endocytosis
;
physiology
;
Insulin
;
metabolism
;
Insulin-Secreting Cells
;
metabolism
;
pathology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Patch-Clamp Techniques
;
Photolysis
;
Primary Cell Culture
6.Construction and application of a management program for arm lymphedema prevention in postoperative breast cancer patients
Yanyan WANG ; Liangyi YAO ; Xin CHEN ; Ruqing LI ; Mengdi CAO ; Xueke QIAN ; Yanjin LIU ; Xing LI ; Yang CHEN ; Qing ZHAO
Chinese Journal of Nursing 2024;59(19):2309-2318
Objective To construct a management program for upper limb lymphedema prevention in postopera-tive breast cancer patients and to evaluate its effectiveness.Methods The first draft of the upper limb lymphede-ma prevention and management protocol for postoperative breast cancer patients was constructed on the basis of ev-idence summaries and qualitative interviews,and 2 rounds of correspondence were conducted in December 2022.Using the convenience sampling method,patients undergoing surgery for malignant tumours in the breast surgery de-partment of a tertiary-level hospital in Zhengzhou City were selected as the study subjects,and 58 patients admitted from January to March 2023 were included in the experimental group according to the time of their first visit.57 patients admitted from July to December 2022 were included in the control group and were given routine care.The rates of lymphedema occurrence,upper limb function score and patients'adherence to lymphedema prevention be-haviours after 1,3,and 6 months of intervention were compared between the 2 groups.Results The valid ques-tionnaire recovery rates of the 2 rounds of expert correspondence were 92.59%and 100%,and the authority coeffi-cients of the experts were 0.940 and 0.950,and the Kendall's harmony coefficients were 0.228 and 0.254,respec-tively(P<0.00 1).The coefficients of variation of the 2nd round of correspondence were 0.07~0.24.The final draft of the programme included 5 first-level entries,12 second-level entries,and 32 third-level entries.During the appli-cation of the programme,a total of 5 cases were dislodged,and 55 cases were finally included in each of the ex-perimental and control groups.The results of repeated measures ANOVA showed that there was an interaction ef-feet between the upper limb function scores and lymphedema prevention behavior compliance scores before inter-vention and at 1,3,and 6 months after discharge between the 2 groups(P<0.05).Simple effects analysis showed that at 1,3,and 6 months after discharge,the upper limb function score and lymphedema prevention behavior com-pliance score of the experimental group were better than those of the control group,and the differences were sta-tistically significant(P<0.05).At 6 months post-intervention,the difference in the occurrence of lymphedema was statistically significant when comparing the 2 groups(P=0.032).Adverse events such as subcutaneous bruising and falls did not occur in either group.Conclusion The upper limb lymphoedema prevention and management pro-gramme for postoperative breast cancer patients constructed in this study is scientific,feasible and safe,and can ef-fectively reduce the incidence of lymphoedema in patients and improve their quality of life.